Literature DB >> 34134882

Expanding buprenorphine treatment to people experiencing homelessness through a mobile, multidisciplinary program in an urban, underserved setting.

David T O'Gurek1, Jillian Jatres2, Jonetta Gibbs2, Ian Latham2, Byron Udegbe2, Kathleen Reeves2.   

Abstract

BACKGROUND AND OBJECTIVES: Inequities in access to buprenorphine treatment remain despite measures to increase access to treatment. "Begin the Turn," a low-barrier, multidisciplinary mobile care unit with access to outreach services, counseling, case management, and buprenorphine treatment addresses these disparities in an urban setting.
METHODS: Retrospective medical record review of patients during the initial 6 months of operation abstracted patient demographics and clinical data, including 10 categories of adverse childhood experiences (ACEs) using a total number of ACEs (ACE score) and measuring scores greater than or equal to 4 given higher risk of chronic disease states at this level. The study collected data in electronic data capture tools. The study assessed retention rates at 1, 3, and 5 months.
RESULTS: Among the 147 individuals who received care, the mean age was 39.6 years and median onset of opioid use was 21 years of age. Among study participants, 67.3% (n = 99) reported IV use, 91.9% (n = 135) reported previous experiences with addiction treatment, and 49.7% (n = 73) had previously suffered an overdose. Adverse Childhood Experiences surveys demonstrated a mean score of 4.6 (n = 141), with 63.1% (n = 89) having a score of 4 or greater. The percentages of patients retained in care at 1, 3, and 5 months were 61.2%, 36.6%, and 27.6%, respectively. CONCLUSION AND SCIENTIFIC SIGNIFICANCE: The program serves a population with high rates of trauma and overdose. The program can serve as a model for treatment for this population.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Buprenorphine; Homelessness; Opioid use disorder; Trauma

Mesh:

Substances:

Year:  2021        PMID: 34134882     DOI: 10.1016/j.jsat.2021.108342

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  4 in total

1.  Low-threshold Buprenorphine Treatment in a Syringe Services Program: Program Description and Outcomes.

Authors:  Andrea Jakubowski; Brianna L Norton; Benjamin T Hayes; Brent E Gibson; Christine Fitzsimmons; L Synn Stern; Franklin Ramirez; Mercedes Guzman; Susan Spratt; Pia Marcus; Aaron D Fox
Journal:  J Addict Med       Date:  2021-11-12       Impact factor: 4.647

2.  The Emergency Department Longitudinal Integrated Care (ED-LINC) intervention targeting opioid use disorder: A pilot randomized clinical trial.

Authors:  Lauren K Whiteside; Ly Huynh; Sophie Morse; Jane Hall; William Meurer; Caleb J Banta-Green; Hannah Scheuer; Rebecca Cunningham; Mark McGovern; Douglas F Zatzick
Journal:  J Subst Abuse Treat       Date:  2021-11-24

3.  Telehealth for opioid use disorder treatment in low-barrier clinic settings: an exploration of clinician and staff perspectives.

Authors:  Shoshana V Aronowitz; Eden Engel-Rebitzer; Abby Dolan; Kehinde Oyekanmi; David Mandell; Zachary Meisel; Eugenia South; Margaret Lowenstein
Journal:  Harm Reduct J       Date:  2021-11-25

4.  Barriers and facilitators to opioid agonist treatment (OAT) engagement among individuals released from federal incarceration into the community in Ontario, Canada.

Authors:  Cayley Russell; Michelle Pang; Frishta Nafeh; Shanna Farrell Macdonald; Dena Derkzen; Jürgen Rehm; Benedikt Fischer
Journal:  Int J Qual Stud Health Well-being       Date:  2022-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.